Back to HomeBeta

ICD-10 Coding for Lymph Node Disorders(C77.4, R59.9)

Complete ICD-10-CM coding and documentation guide for Lymph Node Disorders. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

LymphadenopathyLymphadenitisLymph Node Metastasis

Related ICD-10 Code Ranges

Complete code families applicable to Lymph Node Disorders

C77-C79Primary Range

Secondary and unspecified malignant neoplasm of lymph nodes

This range covers metastatic involvement of lymph nodes, crucial for oncology coding.

Enlarged lymph nodes

Used for non-specific lymphadenopathy without confirmed malignancy.

Acute lymphadenitis

Covers inflammatory conditions of lymph nodes, often due to infection.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C77.4Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodesUse when there is confirmed metastatic disease in the inguinal lymph nodes.
  • Pathology report confirming metastasis
  • Imaging showing lymph node enlargement with suspicious characteristics
R59.9Enlarged lymph nodes, unspecifiedUse when lymph node enlargement is noted but not specified or confirmed as malignant.
  • Physical exam noting enlarged nodes without specific location
  • Lack of pathological confirmation of malignancy

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for lymph node metastasis

Essential facts and insights about Lymph Node Disorders

The ICD-10 code for lymph node metastasis is C77.4, used for secondary malignant neoplasm of inguinal and lower limb lymph nodes.

Primary ICD-10-CM Codes for lymph node

Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed metastatic disease in lymph nodes

coding Criteria

  • Primary neoplasm must be coded first if known

Applicable To

  • Metastasis to inguinal lymph nodes

Excludes

  • Primary neoplasm of lymph nodes

Clinical Validation Requirements

  • Pathology report confirming metastasis
  • Imaging showing lymph node enlargement with suspicious characteristics

Code-Specific Risks

  • Misclassification if primary site is not confirmed
  • Incorrect sequencing if primary neoplasm is not coded first

Coding Notes

  • Ensure documentation specifies the metastatic nature and location of lymph nodes.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Resection of inguinal lymph node, open approach

07TJ0ZZ
Use with C77.4 when a surgical procedure is performed.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Localized enlarged lymph nodes

R59.0
Use R59.0 for non-malignant localized lymph node enlargement.

Acute lymphadenitis of face, head and neck

L04.1
Use L04.1 for acute inflammatory conditions with infection signs.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Lymph Node Disorders to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C77.4.

Impact

Clinical: May lead to inappropriate treatment decisions, Regulatory: Non-compliance with coding standards, Financial: Potential for denied claims or reduced reimbursement

Mitigation Strategy

Always document the side of the body affected., Use templates that prompt for laterality.

Impact

Reimbursement: May lead to incorrect DRG assignment, Compliance: Increases risk of audit due to lack of specificity, Data Quality: Impacts accuracy of clinical data

Mitigation Strategy

Specify the location or use R59.9 for unspecified cases.

Impact

High risk of audit if documentation does not support metastatic coding.

Mitigation Strategy

Ensure all metastatic codes are supported by pathology reports.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Lymph Node Disorders, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Lymph Node Disorders

Use these documentation templates to ensure complete and accurate documentation for Lymph Node Disorders. These templates include all required elements for proper coding and billing.

Oncology Progress Note

Specialty: Oncology

Required Elements

  • Subjective symptoms
  • Objective findings
  • Assessment and plan

Example Documentation

**Subjective**: Reports weight loss and night sweats. **Objective**: 2.5 cm firm left cervical node. **Assessment**: Metastatic node confirmed by biopsy. **Plan**: Excisional biopsy planned.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has enlarged lymph nodes.
Good Documentation Example
Patient presents with a 2.5 cm firm, fixed left cervical lymph node, biopsy confirmed metastatic melanoma.
Explanation
The good example provides specific location, size, and pathological confirmation, supporting accurate coding.

Need help with ICD-10 coding for Lymph Node Disorders? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more